P&G Teams With Firm To Turn Microbes Into Functional Ingredient "Factories"
This article was originally published in The Rose Sheet
Executive Summary
Procter & Gamble and Emeryville, Calif.-based Amyris Inc. have entered into a collaborative agreement to leverage the biotech firm's genetically engineered yeast in the development of personal-care ingredients
You may also be interested in...
Amyris Making Headway In Fermentation-Derived Cannabinoids; CBD Could Hit Market In Early 2020
Synthetic biology firm Amyris has shipped to partner Lavvan its first cannabinoid produced via genetically engineered yeast. While Amyris’ announcement does not identify the specific cannabinoid, Lavvan leadership indicated in March 2019 that fermentation-derived CBD would be first to market, representing potential purity and value benefits compared with CBD extracted from the cannabis plant.
P&G/Pantene Debuts Plant-Based Hair-Care Packaging In Sustainability Race
Procter & Gamble’s Pantene unit is rolling out Pro-V Nature Fusion shampoo and conditioner products in primarily plant-based plastic bottles, demonstrating the firm’s leadership in an increasingly sustainable industry.
P&G/Pantene Debuts Plant-Based Hair-Care Packaging In Sustainability Race
Procter & Gamble’s Pantene unit is rolling out Pro-V Nature Fusion shampoo and conditioner products in primarily plant-based plastic bottles, demonstrating the firm’s leadership in an increasingly sustainable industry.